COECSA, Journal, Ophthalmology
Reasons for delay in presentation and treatment of retinoblastoma patients at the Kenyatta National Hospital, Kenya
PDF

Keywords

Barriers
Delay
Retinoblastoma
Kenyatta National Hospital

How to Cite

I, M., K, K., & M, N. (2020). Reasons for delay in presentation and treatment of retinoblastoma patients at the Kenyatta National Hospital, Kenya. The Journal of Ophthalmology of Eastern, Central and Southern Africa, 20(2). Retrieved from https://joecsa.coecsa.org/index.php/joecsa/article/view/115

Abstract

Background: Retinoblastoma is a curable cancer when detected early. Delay in presentation and
management has been seen as a major contributor affecting outcome. By addressing the factors causing
delay an increase in the survival rate of the affected children is likely.
Objective: To determine the reasons for delay in presentation and management of retinoblastoma
patients at the Kenyatta National Hospital (KNH).
Methodology: A cross sectional hospital based study carried out at the Kenyatta National Hospital. Data
was collected after obtaining consent from the parents/guardians of retinoblastoma patients, using a
semi-structured questionnaire.
Results: A total of 91 parents/guardians of 64 patients took part in the study. The most common reasons
for delay in presentation were financial constraints (25.0%) and lack of awareness about the disease
(6.3%). There was no association between delayed presentation and parent’s or caregiver’s employment,
education level, having health insurance or living in rural or urban areas (p>0.05). Reasons for delay in
treatment in the hospital included other concurrent illnesses (1.6%), atypical features of the disease
(1.6%), lack of awareness about the condition (1.6%) and caregivers’ fear of enucleation (3.1%).
Conclusions: Financial constraints and lack of awareness about retinoblastoma were the commonest
causes of delay in presentation to a health facility. The caregivers’ fear of enucleation was the most
recurrent reason for delay in treatment at the referral hospital.

PDF

References

Makite IN, Kimani K, Njuguna M. Delay in

presentation and management of retinoblastoma

patients at the Kenyatta National Hospital,

Nairobi, Kenya. J Ophthalmol Eastern Central

and Southern Afr. 2015; 19(2):46-49.

Bekibele CO, Ayede AI, Asaolu OO, Brown BJ.

Retinoblastoma: the challenges of management in

Ibadan, Nigeria. J Pediat Hematol Oncol. 2009;

(8): 552-555.

Kimani K, Ilako D, Kollmann M. A review of

retinoblastoma, presentation, diagnosis, and

management at KNH. Nairobi: MMed thesis,

University of Nairobi, 2000.

Haik BG, Siedlecki A, Ellsworth RM, et al.

Documented delays in the diagnosis of

retinoblastoma. Annals Ophthalmol. 1985; 17:

-732.

Ling-Yuh Kao, Wei-Wen Su, Ya-Wen Lin.

Retinoblastoma in Taiwan: Survival and

clinical characteristics 1978–2000. Japanese J

Ophthalmol. 2002; 46(5): 577-580.

Chantada G, Fandiño A, Manzitti J, Urrutia L,

Schvartzman E. Late diagnosis of retinoblastoma

in a developing country. Arch Dis Child. 1999;

: 171-174.

Rodriguez-Galindo C, Wilson MW, Chantada G,

et al. Retinoblastoma: One World, One Vision.

Pediatrics. 2008; 122(3): e763-e770.

Nyamori JM, Kimani K, Njuguna MW, Dimaras H.

The incidence and distribution of retinoblastoma

in Kenya. Br J Ophthalmol. 2012; 96: 141–143.

Downloads

Download data is not yet available.